Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity
Khadija Khan, Farina Karim, Yashica Ganga, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian, et al.
Nature (2022) Vol. 608, Iss. 7923, pp. 593-602
Open Access | Times Cited: 1195
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Qian Wang, Yicheng Guo, Sho Iketani, et al.
Nature (2022) Vol. 608, Iss. 7923, pp. 603-608
Open Access | Times Cited: 705
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Aekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2422-2433.e13
Open Access | Times Cited: 668
Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 406
Covid-19 Vaccines — Immunity, Variants, Boosters
Dan H. Barouch
New England Journal of Medicine (2022) Vol. 387, Iss. 11, pp. 1011-1020
Open Access | Times Cited: 378
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3992-4007.e16
Open Access | Times Cited: 238
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
Science (2022) Vol. 378, Iss. 6620, pp. 619-627
Open Access | Times Cited: 193
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
Jasmin Quandt, Alexander Muik, Nadine Salisch, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 187
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Akatsuki Saito, Tomokazu Tamura, Jiří Zahradník, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1540-1555.e15
Open Access | Times Cited: 148
What Omicron’s BA.4 and BA.5 variants mean for the pandemic
Ewen Callaway
Nature (2022) Vol. 606, Iss. 7916, pp. 848-849
Closed Access | Times Cited: 127
The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic – Correspondence
Ranjan K. Mohapatra, Venkataramana Kandi, Ashish K. Sarangi, et al.
International Journal of Surgery (2022) Vol. 103, pp. 106698-106698
Open Access | Times Cited: 93
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study
Sara Carazo, Danuta M. Skowronski, Marc Brisson, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. 45-55
Open Access | Times Cited: 84
Update on the omicron sub‐variants BA.4 and BA.5
Trina Ekawati Tallei, Saad Alhumaid, Zainab AlMusa, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 75
Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection
Lin Yao, Ka-Li Zhu, Xiaolin Jiang, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 8, pp. 1116-1117
Open Access | Times Cited: 71
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations
Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 66
COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron)
Wan Yang, Jeffrey Shaman
eLife (2022) Vol. 11
Open Access | Times Cited: 55
Are COVID surges becoming more predictable? New Omicron variants offer a hint
Ewen Callaway
Nature (2022) Vol. 605, Iss. 7909, pp. 204-206
Closed Access | Times Cited: 54
SARS-CoV-2 variants – Evolution, spike protein, and vaccines
Kai-Wei K. Chen, Daniel Tsung‐Ning Huang, Li‐Min Huang
Biomedical Journal (2022) Vol. 45, Iss. 4, pp. 573-579
Open Access | Times Cited: 49
Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA.2.12.1, BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 47
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
Iris Medits, David Niklas Springer, Marianne Graninger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses
Peter Halfmann, Steven J. Frey, Kathryn Loeffler, et al.
EBioMedicine (2022) Vol. 86, pp. 104341-104341
Open Access | Times Cited: 36
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5
Qian Wang, Yicheng Guo, Sho Iketani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 32
Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant
David Niklas Springer, Thomas Perkmann, Claudia Jani, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top